Showing results (1951-1960 of 2,238) with videos related to
Sort By:
Pageof 224
The British Journal of Radiology|May 6, 2025
FLASH-induced DNA damage reduction measured in vitro correlates with effective oxygen depletion determined in silico: further support for oxygen depletion contributing to FLASH's reduced damage burden in vitroBethany Rothwell, Christian R Cooper, Donald J L Jones, et al.Leukemia|November 29, 2016
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myelomaK T Siu, J Ramachandran, A J Yee, et al.Journal of Clinical Pharmacy and Therapeutics|January 24, 2008
Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006L Guillaume, R Cooper, A Avery, et al.American Journal of Clinical Oncology|June 1, 1983
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213D V Jackson, H B Wells, D R White, et al.Oncology (Williston Park, N.Y.)|May 1, 1990
Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trialsA B Kornblith, J Anderson, D F Cella, et al.BMC Public Health|April 18, 2014
School travel mode, parenting practices and physical activity among UK Year 5 and 6 childrenRussell Jago, Lesley Wood, Simon J Sebire, et al.Protein Science : a Publication of the Protein Society|September 27, 2020
Covid-19.bioreproducibility.org: A web resource for SARS-CoV-2-related structural modelsDariusz Brzezinski, Marcin Kowiel, David R Cooper, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|December 13, 2021
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeaeNader S Abutaleb, Ahmed E M Elhassanny, Alessio Nocentini, et al.Proceedings of the National Academy of Sciences of the United States of America|July 24, 2023
Pinoresinol rescues developmental phenotypes of Arabidopsis phenylpropanoid mutants overexpressing FERULATE 5-HYDROXYLASEFabiola Muro-Villanueva, Leonard D Pysh, Hoon Kim, et al.Cancer|April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trialH B Muss, V Howard, F Richards, et al.Pageof 224